Recommendations for Surveillance and Management of Recurrent Esophageal Cancer Following Endoscopic Therapies

Surg Clin North Am. 2021 Jun;101(3):415-426. doi: 10.1016/j.suc.2021.03.004.

Abstract

With advancing endoscopic technology and screening protocols for Barrett disease, more patients are being diagnosed with early-stage esophageal cancer. These early-stage patients may be amendable to endoscopic therapies, such as endomucosal resection and ablation. These therapies may minimize morbidity, but the elevated risk of recurrence cannot be overlooked. This article reports outcomes and recommendations for surveillance and management of recurrent esophageal cancer following endoscopic therapies.

Keywords: Endoscopic treatment; Esophageal malignancy; Minimally invasive esophagectomy.

Publication types

  • Review

MeSH terms

  • Ablation Techniques / methods
  • Adenocarcinoma / diagnosis
  • Adenocarcinoma / pathology
  • Adenocarcinoma / therapy
  • Aftercare / methods*
  • Carcinoma, Squamous Cell / diagnosis
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / therapy
  • Endoscopic Mucosal Resection
  • Esophageal Neoplasms / diagnosis*
  • Esophageal Neoplasms / pathology
  • Esophageal Neoplasms / therapy*
  • Esophagectomy / methods
  • Esophagoscopy*
  • Humans
  • Neoplasm Recurrence, Local / diagnosis*
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / therapy*
  • Neoplasm Staging